Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Rosa-Neto

Showing results (1-10 of 503) with videos related to

Pageof 51
Sort By:
Nature Reviews. Neurology|October 23, 2013
Dementia: Disclosure of results to participants in dementia researchSerge Gauthier, Pedro Rosa-Neto
Aging|September 14, 2022
<i>In vivo</i> tau staging in Alzheimer's diseaseJoseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMin Chu, Liyong Wu, Pedro Rosa-Neto
Molecular Diagnosis & Therapy|December 23, 2011
Use of biomarkers in clinical trials of Alzheimer disease: from concept to applicationLiyong Wu, Pedro Rosa-Neto, Serge Gauthier
Brain : a Journal of Neurology|August 8, 2018
Optimal use of cholinergic drugs in Alzheimer's diseaseSerge Gauthier, Nathan Herrmann, Pedro Rosa-Neto
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLiyong Wu, Min Chu, Pedro Rosa-Neto
Aging|January 9, 2023
Applications of Alzheimer's disease staging to clinical trialsJoseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Handbook of Clinical Neurology|May 8, 2025
Cholinergic therapy in Alzheimer diseaseSerge Gauthier, Joseph Therriault, Pedro Rosa-Neto
Alzheimer'S Research & Therapy|February 26, 2014
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physiciansPedro Rosa-Neto, Ging-Yuek Hsiung, Mario Masellis, et al.
Neuroimage|June 29, 2004
Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PETPedro Rosa-Neto, Doris J Doudet, Paul Cumming
Pageof 51

Showing results (1-10 of 503) with videos related to

Sort By:
Pageof 51
Nature Reviews. Neurology|October 23, 2013
Dementia: Disclosure of results to participants in dementia researchSerge Gauthier, Pedro Rosa-Neto
Aging|September 14, 2022
<i>In vivo</i> tau staging in Alzheimer's diseaseJoseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersMin Chu, Liyong Wu, Pedro Rosa-Neto
Molecular Diagnosis & Therapy|December 23, 2011
Use of biomarkers in clinical trials of Alzheimer disease: from concept to applicationLiyong Wu, Pedro Rosa-Neto, Serge Gauthier
Brain : a Journal of Neurology|August 8, 2018
Optimal use of cholinergic drugs in Alzheimer's diseaseSerge Gauthier, Nathan Herrmann, Pedro Rosa-Neto
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersLiyong Wu, Min Chu, Pedro Rosa-Neto
Aging|January 9, 2023
Applications of Alzheimer's disease staging to clinical trialsJoseph Therriault, Serge Gauthier, Pedro Rosa-Neto
Handbook of Clinical Neurology|May 8, 2025
Cholinergic therapy in Alzheimer diseaseSerge Gauthier, Joseph Therriault, Pedro Rosa-Neto
Alzheimer'S Research & Therapy|February 26, 2014
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physiciansPedro Rosa-Neto, Ging-Yuek Hsiung, Mario Masellis, et al.
Neuroimage|June 29, 2004
Gradients of dopamine D1- and D2/3-binding sites in the basal ganglia of pig and monkey measured by PETPedro Rosa-Neto, Doris J Doudet, Paul Cumming
Pageof 51